GBB Closed The A Round Financing With Newly Joined FutureX Capital

Published by
The Street

By PR Newswire HONG KONG, Dec. 31, 2021 /PRNewswire/ — Great Bay Bio (GBB), an AI-enabled biotechnology company, announces the participation of FutureX Capital in its Series A round fundraising. Great Bay Bio finished A round financing of near USD 10 million on December 1, 2021. The investors include Promixa Ventures, GL Ventures, Alibaba Entrepreneurs Fund, Alon Capital and FutureX Capital. “Thanks for the compelling support of FutureX Capital. We are looking forward to working with FutureX to enrich Great Bay Bio’s entrepreneurial ecosystem and accelerate the pace of the application of cutt…

Read More

See also  Buy Biotech Stocks? Cathie Wood's Ark Thinks So (And, Here's Why)

Leave a Reply